FindTrial
Sign In

EVALUATION OF OVULATION INDUCTION BY CLOMIPHENE CITRATE IN LATE LUTEAL PHASE

EVALUATION OF OVULATION INDUCTION BY CLOMIPHENE CITRATE IN LATE LUTEAL PHASE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/000366
Enrollment
104
Registered
2010-11-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: clomiphene citrate in the late luteal phase: clomiphene citrate 100mg daily from day 26 of cycle preceding intrauterine insemination cycle given for 5 days Control Intervention1: clomip

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Infertile women with anovulatory or unexplained infertility undergoing ovulation induction and intrauterine insemination

Exclusion criteria

Exclusion criteria: Women with tubal block , or having partners with oligoasthenozoospermia

Design outcomes

Primary

MeasureTime frame
conception and endometrial thicknessTimepoint: endometrial thickness on day of HCG trigger for ovulation—

Secondary

MeasureTime frame
number of follicles and day of mature folliculogenesisTimepoint: day of cycle when follicles are 18mm or more—

Countries

India

Contacts

Public ContactAnjoo Agarwal

Deptt of Ob/Gyn CSM Medical University, Lucknow

anjooa@gmail.com0522-4045857

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026